Post-Surgical Ablative or Adjuvant Radioiodine Therapy Has No Impact on Outcome in 1–4 cm Differentiated Thyroid Cancers without Extrathyroidal Extension

Whether to conduct remnant ablation or adjuvant radioactive iodine (RAI) therapy in patients with intrathyroidal differentiated thyroid carcinoma (DTC), sized 1.1–4 cm, is debated. We evaluated the impact of RAI on outcome in this category of DTCs. We retrospectively enrolled 308 patients submitted...

Descripción completa

Detalles Bibliográficos
Autores principales: De Leo, Simone, Trevisan, Matteo, Colombo, Carla, Gazzano, Giacomo, Palazzo, Sonia, Vicentini, Leonardo, Persani, Luca, Fugazzola, Laura
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8509406/
https://www.ncbi.nlm.nih.gov/pubmed/34640469
http://dx.doi.org/10.3390/jcm10194452

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8509406/
https://www.ncbi.nlm.nih.gov/pubmed/34640469
http://dx.doi.org/10.3390/jcm10194452

Ejemplares similares